Cargando…
Cross-platform comparisons for targeted bisulfite sequencing of MGISEQ-2000 and NovaSeq6000
BACKGROUND: An accurate and reproducible next-generation sequencing platform is essential to identify malignancy-related abnormal DNA methylation changes and translate them into clinical applications including cancer detection, prognosis, and surveillance. However, high-quality DNA methylation seque...
Autores principales: | Sun, Jin, Su, Mingyang, Ma, Jianhua, Xu, Minjie, Ma, Chengcheng, Li, Wei, Liu, Rui, He, Qiye, Su, Zhixi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426093/ https://www.ncbi.nlm.nih.gov/pubmed/37582783 http://dx.doi.org/10.1186/s13148-023-01543-4 |
Ejemplares similares
-
Comparative performance of the GenoLab M and NovaSeq 6000 sequencing platforms for transcriptome and LncRNA analysis
por: Liu, Yongfeng, et al.
Publicado: (2021) -
Correction to: Comparative performance of the GenoLab M and NovaSeq 6000 sequencing platforms for transcriptome and LncRNA analysis
por: Liu, Yongfeng, et al.
Publicado: (2022) -
Comparison of the MGISEQ-2000 and Illumina HiSeq 4000 sequencing platforms for RNA sequencing
por: Jeon, Sol A, et al.
Publicado: (2019) -
Evaluation of the MGISEQ-2000 Sequencing Platform for Illumina Target Capture Sequencing Libraries
por: Lang, Jidong, et al.
Publicado: (2021) -
Comparative Performance of the MGISEQ-2000 and Illumina X-Ten Sequencing Platforms for Paleogenomics
por: Zhu, Kongyang, et al.
Publicado: (2021)